Skip to main content

Stem Cell-Based Regenerative Therapies for Functional Endocrine System Organs: Tissue Engineering Applications and Future Strategies

  • Living reference work entry
  • First Online:
Handbook of Stem Cell Applications

Abstract

The endocrine system is a complex network that controls and regulates essential physiological reactions in the human body through certain chemical messengers called hormones in response to a signal. This system consists of highly vascularized ductless endocrine organs, including the pituitary, thyroid, parathyroid, adrenal glands, gonads, and pancreas. Hormones secreted into the bloodstream circulate as signaling molecules and have vital roles in maintaining homeostasis through cellular communication due to their overall effects on target cells via binding to specific receptors throughout the body. Recently, significant progress has been made in stem cell applications of endocrine system organs, with studies bringing together experts from different scientific backgrounds, such as developmental biologists, endocrinologists, and tissue engineers. Thanks to the basic research on the generation of endocrine system organs in embryonic development, the literature on the role of the stem/progenitor cells of endocrine organs in the organogenesis and self-renewal of these organs has expanded. In light of these improvements, scientists are developing different treatment approaches for various endocrine diseases, metabolic disorders, and damaged tissue/organ repair through stem cells obtained from different sources. This chapter will comprehensively discuss the recent advances and promising stem cell-based applications on endocrine system organs and evaluate their therapeutic and clinical potential.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

3D:

Three dimensional

3β-HSD:

3β-hydroxysteroid dehydrogenase

5-ALA:

5-aminolevulinic acid hydrochloride

ACTH:

Adrenocorticotrophic hormone

ADSCs:

Adipose-derived MSCs

AGP:

Adrenogonadal primordium

AP:

Anterior pituitary

BMMSCs:

Bone marrow-derived MSCs

BMP4:

Bone morphogenetic factor 4

Ca2+:

Ionized calcium

cAMP:

Cyclic adenosine monophosphate

CaSR:

Calcium-sensing receptors

CCL21:

C-C motif chemokine ligand 21

CPH:

Congenital pituitary hypoplasia

Cxcr4:

C-X-C motif chemokine receptor 4

CYC:

Cyclopamine-KAAD

CYP11A1:

Cytochrome P450 family 11 subfamily A member 1

DAPT:

Dual-antiplatelet therapy

DAX-1:

Dosage-sensitive sex-reversal, adrenal hypoplasia congenital, X chromosome

EDS:

Ethane dimethane sulfonate

ESCs:

Embryonic stem cells

Ex4:

Exendin-4

EYA1:

Eyes absent homolog 1

FBS:

Fetal bovine serum

FGF:

Fibroblast growth factor

FOXE1:

Forkhead box E1

FSH:

Follicle-stimulating hormone

GCM2:

Glial cell missing-2

GFP:

Green fluorescent protein

GH:

Growth hormone

GO:

Graves’ ophthalmopathy

HbA1c:

Hemoglobin A1c

HHEX:

Hematopoietically-expressed homeobox protein

HRT:

Hormonal replacement therapy

HyperPTH:

Hyperparathyroidism

HypoPTH:

Hypoparathyroidism

IGF-1:

Insulin-like growth factor-1

IHC:

Immunohistochemistry

iPSCS:

Induced pluripotent stem cells

ISSCR:

International Society for Stem Cell Research

LC:

Leydig cells

LH:

Luteinizing hormone

LHR:

Luteinizing hormone receptor

MSCs:

Mesenchymal stem cells

MSH:

Melanocyte-stimulating hormone

NIS:

Na+/I symporter

NKX2-1:

NK2 homeobox 1

NKX6-1:

NK homeobox factor 6.1

OLCs:

Oocyte-like cells

OTX2:

Orthodenticle homeobox 2

PA:

Pituitary adenomas

PAX2:

Paired box 2

PAX8:

Paired box 8

PDGFR:

Platelet-derived growth factor

PDX-1:

Pancreatic and duodenal homeobox 1

PEC-01:

Pancreatic progenitor cell

PG:

Pituitary gland

PKC:

Protein kinase C

POF:

Premature ovarian failure

PP:

Posterior pituitary

PRL:

Prolactin

PSCs:

Pluripotent stem cells

PT:

Parathyroid

PTX:

Parathyroidectomy

RA:

Retinoic acid

ROS:

Reactive oxygen species

r-PTH:

Recombinant human PTH

Shh:

Sonic hedgehog

SIX1:

Sine oculis homeobox 1

SLC5A5:

Sodium/iodide cotransporter

SLCs:

Stem Leydig cells

Sox2:

SRY (sex-determining region Y)-box 2

T1D:

Type 1 diabetes

T2D:

Type 2 diabetes

T3:

Triiodothyronine

T4:

Thyroxine

TG:

Thyroglobulin

TMSCs:

Tonsil-derived mesenchymal stem cells

TPO:

Thyroid peroxidase

TSH:

Thyroid-stimulating hormone

TSHR:

Thyroid-stimulating hormone receptor

TTF1:

Thyroid transcription factor 1

UCMSCs:

Umbilical cord-derived MSCs

WNT:

Wingless-INT1

WT1:

Wilms tumor protein homolog

References

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Singapore Pte Ltd.

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Karabıyık Acar, Ö., Nozhatzadeh, G.D., Kurtoglu, N., Aysan, E. (2023). Stem Cell-Based Regenerative Therapies for Functional Endocrine System Organs: Tissue Engineering Applications and Future Strategies. In: Haider, K.H. (eds) Handbook of Stem Cell Applications. Springer, Singapore. https://doi.org/10.1007/978-981-99-0846-2_20-1

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-0846-2_20-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-0846-2

  • Online ISBN: 978-981-99-0846-2

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics